Raquel Hontecillas
Founder at Nutritional Immunology & Molecular Medicine Laboratory
Profile
Raquel Hontecillas is the founder and the Chief Scientific Officer & Co-Director of the Nutritional Immunology & Molecular Medicine Laboratory, founded in 2002.
She is also the Chief Scientific Officer of Biotherapeutics, Inc. since 2008.
Dr. Hontecillas's former positions include being a Professor at Virginia Polytechnic Institute & State University from 2008 to 2020, and the Chief Scientific Officer of Landos Biopharma, Inc. from 2017 to 2022.
Dr. Hontecillas's education includes a doctorate from Iowa State University and an undergraduate degree from Universidad Complutense de Madrid.
Raquel Hontecillas active positions
Companies | Position | Start |
---|---|---|
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Chief Tech/Sci/R&D Officer | 2008-09-30 |
Nutritional Immunology & Molecular Medicine Laboratory | Founder | 2002-06-30 |
Former positions of Raquel Hontecillas
Companies | Position | End |
---|---|---|
LANDOS BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 2022-04-04 |
Virginia Polytechnic Institute & State University | Corporate Officer/Principal | 2020-06-30 |
Training of Raquel Hontecillas
Iowa State University | Doctorate Degree |
Universidad Complutense de Madrid | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
LANDOS BIOPHARMA, INC. | Health Technology |
Private companies | 2 |
---|---|
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |
Nutritional Immunology & Molecular Medicine Laboratory |
- Stock Market
- Insiders
- Raquel Hontecillas